Plenary: Tumor Agnostic Therapies - Revolutionizing Cancer Treatment: From Tissue-Specific to Target-Driven

This session explores the groundbreaking potential of tumor-agnostic therapies in precision oncology, shifting the focus from tumor origin to molecular alterations such as gene fusions and signaling pathways. The session will highlight recent breakthroughs, the integration of artificial intelligence in personalized medicine, and the development of novel treatment paradigms. Key challenges, including affordability, equitable access, and the need for sustained innovation will be addressed.